
When patients are genuine partners in health AI — not an afterthought — everyone wins. Tech companies build better products, health systems see stronger outcomes, and patients and caregivers gain real agency over their care. That's Patient Health Capital, and it drives ROI for every stakeholder in the ecosystem.
The data is clear: when patients are genuine partners in health AI development, every stakeholder in the ecosystem sees measurable returns.
20%
Higher Trial Success Rate
Patient-centric clinical trials are ~20% more likely to succeed than conventionally designed studies.
Source: Economist Intelligence Unit
2×
Faster Patient Recruitment
Patient-centered trials recruit 100 participants in ~4 months vs. 7 months for standard trials — cutting timelines nearly in half.
Source: Clinical Leader, 2024
$100M+
Cost Savings from AI Adoption
Health systems that deploy AI with patient input have reported cost savings exceeding $100M annually through reduced readmissions and improved care navigation.
Source: Becker's Hospital Review, 2025
33+
Regulatory Bodies Require Patient Input
Global regulatory agencies and HTA bodies — including FDA, EMA, and NICE — now formally incorporate patient experience data in AI/ML product review processes.
Source: Bertelsen et al., 2024
Tech Companies & AI Developers
Products built with patient input launch faster, achieve higher adoption, and face fewer regulatory hurdles.
Pharmaceutical & Life Sciences
Patient-centered trial design reduces dropout, accelerates recruitment, and strengthens real-world evidence packages.
Health Systems & Payers
AI tools co-designed with patients drive adherence, reduce avoidable utilization, and improve HEDIS and CAHPS scores.
Patients & Caregiver Communities
Meaningful partnership means tools that actually fit lived experience — improving outcomes, access, and health equity.

PXI is such a great platform that's going to help us because it involves the patient voice, ensuring that we're building things for the patient—and with the patient, most importantly—not just deciding what we think the patient needs.
The NHC PXI Center is uniquely positioned to bridge the gap between patient communities and the rapidly evolving health AI sector. With founding partners CTA, DiMe, and CHAI — and a new collaboration with Microsoft AI — PXI has the cross-sector credibility to drive patient-centered AI development at scale.
This strategic hub presents recommendations across four pillars: from building AI literacy (LearningLab) to matching innovators with patients (PatientLink), co-designing solutions (ProjectHub), and shaping federal policy (Leadership Alliance). Each pillar has a distinct operational model, revenue strategy, and stakeholder ecosystem.

Build AI Literacy. Empower Advocates.
A curated, interactive learning ecosystem that builds AI readiness among patient advocates, community health workers, and innovators — enabling meaningful, informed dialogue and engagement across the health AI landscape.
Patient Advocacy Organizations
Staff and leadership seeking AI literacy programs for their teams and communities
Individual Patient Advocates
Self-directed learners pursuing certification and practical AI skills
Community Health Workers
Frontline workers integrating AI tools into patient education and navigation
Caregivers & Family Advocates
Caregivers seeking to understand how AI affects care decisions and access
Digital Health Societies & Academies
Organizations providing curriculum, content, and co-development for AI literacy programs
Academic & Research Institutions
Universities and research centers co-developing accredited AI health literacy curricula
Health AI Standards Bodies
Organizations such as CHAI and URAC providing governance frameworks for curriculum alignment
Health Equity Organizations
Groups focused on ensuring AI literacy reaches underserved and marginalized patient communities
Technology Companies
Industry sponsors providing content, tools, compute resources, and co-branded learning programs
Pharmaceutical & Life Sciences Companies
Pharma sponsors funding disease-specific AI literacy tracks for patient communities
Health Philanthropies & Foundations
Foundations funding equitable AI education, digital literacy, and health innovation programs

Connect Innovators with Patient Expertise.
A B2B matchmaking and facilitation service connecting technology companies, pharma, and AI developers with vetted patient organizations and communities for authentic collaboration in research, design, access, and evaluation.
Pharmaceutical & Biotech Companies
R&D and commercial teams seeking patient input for AI-driven drug development and clinical trials
Legacy Technology Companies
Established tech giants (e.g., Microsoft, NVIDIA, Google, AWS, Oracle, IBM) building health AI platforms requiring real-world patient validation
AI & Quantum Health Startups
Early-stage companies applying AI and quantum computing to diagnostics, drug discovery, and patient-facing care tools
Medical Device Manufacturers
Companies developing AI/ML-enabled devices requiring patient preference information (PPI) under MDIC frameworks
Contract Research Organizations
CROs integrating patient perspectives into AI-assisted clinical trial design and execution
Patient Advocacy Organizations
Disease-specific organizations providing vetted patient communities for matching and collaboration
Health AI Standards & Regulatory Bodies
Organizations such as MDIC, CHAI, and URAC providing DPI frameworks and AI validation standards
Health Equity & Community Organizations
Groups ensuring underserved communities are represented in AI audits and trusted tester programs
Technology Industry Sponsors
Tech companies funding PatientLink program operations through subscription or fee-for-service models
Life Sciences Industry Sponsors
Pharma and biotech companies investing in patient-centered AI validation as a competitive differentiator
Venture Capital & Impact Investors
Investors de-risking health tech portfolio companies through patient validation partnerships
Health Philanthropies & Foundations
Foundations funding equity-focused AI validation and patient access to health technology programs

Co-Create Patient-Centered AI Solutions.
An innovation incubator where patients, developers, philanthropists, and decision-makers co-create AI solutions through structured sprints, challenges, and accelerator programs — ensuring patient-defined outcomes drive product success.
Technology Developers & AI Companies
Companies building AI tools with patient co-design embedded from the earliest stages of development
Pharmaceutical Innovation Labs
Pharma R&D and digital health teams co-developing patient support and medication adherence AI programs
Academic Medical Centers
Research institutions and health systems seeking structured patient partnership for AI research projects
Patient & Caregiver Advocacy Organizations
Disease-specific advocacy groups co-designing AI solutions that reflect real patient needs and lived experience
Digital Health & AI Societies
Organizations such as DiMe Society and CTA providing methodology, standards, and co-design facilitation
Health AI Governance Bodies
Organizations such as CHAI integrating responsible AI governance frameworks into co-design processes
Design & Innovation Consultancies
Human-centered design firms facilitating structured co-design sprints and patient journey mapping
Regulatory Science Partners
Organizations such as MDIC aligning co-design outputs with FDA and regulatory science standards
Technology Industry Sponsors
Tech companies providing compute credits, engineering mentorship, and API access for co-design sprints
Life Sciences Industry Sponsors
Pharma and biotech companies funding disease-specific co-design challenges and innovation prizes
Health Philanthropies & Foundations
Foundations funding patient advocate stipends, equity-focused co-design tracks, and rare disease innovation

Shape Policy. Accelerate Patient-Centered AI.
A premium, invitation-only executive consortium that facilitates synergies between patient and AI/technology organization leaders — translating governance standards into policy, advising federal regulators, and hosting the premier annual summit for patient-powered AI.
Join the PXI Community for the Annual Patient-Powered AI Summit, brought to you in partnership with CTA. This summit will include an invite-only half-day workshop for PXI and CTA members, followed by an afternoon of dynamic keynotes and panel discussions. Set for late September 2026 — official date to be announced soon.
Interested in joining the Leadership Alliance?
Connect with the PXI team to explore membership and collaboration opportunities.
Leaders from across health advocacy, technology, policy, and patient communities who have contributed to the NHC AI Affinity Group Meetings and PXI Convenings.

Laura Adams
Senior Advisor
National Academy of Medicine

Brian Anderson
Founder & CEO
Coalition for Health AI (CHAI)

Margaret Anderson
Managing Director
Deloitte

Kimberly Beer
SVP, Policy & External Affairs
National Health Council

Dr. Helen Burstin
President & CEO
Council of Medical Specialty Societies

Shion Chang
Assistant VP
National Health Council

Donna Cryer
Founder, President & CEO
Global Liver Institute

Raul Damas
Partner, Healthcare & Life Sciences Global Lead
Brunswick Group

Damon Davis
Health Policy Advocate

Jennifer Dexter
SVP, Policy
National Health Council

Eric Gascho
Executive Director & Vice President
CRD Associates L.L.C.

Amanda Garzon
Chief Operations Officer
Hydrocephalus Association

Danielle Gewurz
AI Leader
Deloitte

Jennifer Goldsack
Chief Executive Officer
Digital Medicine Society (DiME)

Rachel Gruner
Health Care Lead
Microsoft AI

Heather Flannery
Founder & CEO
AI MINDSystems Impact

David-Alexandre Jost
Chief Technology Innovations Officer
Epilepsy Foundation

Loren Kirk
Senior Director of Strategic Partnerships
Pharmacy Quality Alliance

Julia Komissarchik
CEO & Co-Founder
Glendor, Inc.

KiKi L'Italien
Founder
Big Red M / ASAE

Brian Lloyd
Chief Technology Officer
Immune Deficiency Foundation

Chelsea Magnant
Director
Brunswick Group

Shaye Mandle
Executive Director, AdvaMed Digital Health Tech
AdvaMed

Ian Miller
Associate Director
Digital Medicine Society (DiME)

Spencer Morrissey
Director, PXI Center & Executive Office
National Health Council

Lucy Orr-Ewing
Chief of Staff & Head of Policy
Coalition for Health AI (CHAI)

Diana Pankevich
Director, Science & Innovation Policy
Pfizer

Kapil Parakh
Chief Medical Officer

Caroline Pearson
Executive Director
Peterson Health Technology Institute

Rene Quashie
VP, Digital Health
Consumer Technology Association

Eric Racine
Head, US Public Affairs & Patient Advocacy
Sanofi

Mary Richards
President
Richards Strategies

Randall Rutta
Chief Executive Officer
National Health Council

April Dawn Shinske
Chief Communications & Marketing Officer
The Marfan Foundation

Laura Simpson
Chief Operating Officer
Autoimmune Association

Lilly Stairs
Chief Executive Officer
Chronic Boss Collective

Steve Taylor
President & CEO
Arthritis Foundation

Jeff Todd
President & CEO
Prevent Blindness

Patrick Wayte
SVP, Center for Health Technology & Innovation
American Heart Association

Steve Winawer
Head of Data, Digital & Technology, USBU
Takeda Pharmaceuticals
Interested in speaking at a future NHC AI Initiative Meeting or PXI Convening?
Become a SpeakerThe organizations shaping the future of health AI are already at the table. PXI Collaborators gain structured access to patient partnerships, policy influence, and a cross-sector network that no single organization can replicate alone.
Every month without a seat at this table is a month your competitors are building the relationships, earning the trust, and setting the standards that will define patient-centered AI for the next decade. The window to join as a founding Collaborator is open — but it won't be indefinitely.
Founding Collaborators shape PXI's direction from day one
Priority access to PatientLink matching and ProjectHub co-design
Direct voice in federal AI governance and policy advocacy
Inaugural Annual Patient-Powered AI Summit — late September 2026
Health AI will only reach its full potential when patients are genuine partners — not an afterthought. Sponsoring PXI Center is how your organization helps build the infrastructure that makes that possible.
Sponsoring PXI signals to 200M+ patients and their advocates that your organization is genuinely committed to patient partnership — not just compliance.
PXI's governance frameworks and federal policy work give sponsors a direct line to FDA, CMS, and ARPA-H conversations — with patient voices already embedded.
Sponsors gain priority access to PatientLink's trusted tester network and ProjectHub's co-design infrastructure — cutting months off product validation cycles.
Health AI will only reach its potential when patients are genuine partners. Sponsors don't just fund PXI — they help build the infrastructure that makes the entire ecosystem more equitable and effective.
Sponsorship Tiers
Quantum Level
Premier naming rights across all four PXI pillars
Platinum Level
Named sponsorship of one PXI pillar
Gold Level
Prominent recognition across PXI platforms and events
Silver Level
Recognition on PXI website and materials
Bronze Level
Recognition on PXI website
PXI Convening Sponsor
Named sponsorship of a PXI convening or workshop
Ready to discuss sponsorship? Select your tier of interest and we'll follow up with a tailored sponsorship package.
The organizations shaping the future of health AI are already here. Every day you're not part of PXI is a day your competitors are building relationships, influencing standards, and earning trust that takes years to replicate. The window to be a founding force is open — but not forever.
The Knowledge Edge
Your Direct Line to Patients
Where Ideas Become Impact
The Inner Circle
PXI Center Team · [email protected]